Showing 1 posts of 1 posts found.
India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement